Kingue S., Bakilo L., Ze Minkande J., Fifen I., Gureja Y.P., Razafimahandry H.J.C., Okubadejo N., Mvuala R., Oke D.A., Manga A., Rajaonera T., Nwadinigwe C., Pay Pay E., Rabearivony N.
Department of Cardiology, General Hospital, Yaoundé, Cameroon; Department of Internal Medicine, Clinic Ngaliema, Kinshasa, DRC, Congo; Department of Anaesthesiology and Reanimation, Hospital Gynéco Obstetrique et Pédiatrique, Yaoundé, Cameroon; SANOFI, No
Kingue, S., Department of Cardiology, General Hospital, Yaoundé, Cameroon; Bakilo, L., Department of Internal Medicine, Clinic Ngaliema, Kinshasa, DRC, Congo; Ze Minkande, J., Department of Anaesthesiology and Reanimation, Hospital Gynéco Obstetrique et Pédiatrique, Yaoundé, Cameroon; Fifen, I., SANOFI, North-East Africa, Lagos, Nigeria; Gureja, Y.P., Orthopaedic Department, Princess Marina Hospital, Gaborone, Botswana; Razafimahandry, H.J.C., Antananarivo, Madagascar; Okubadejo, N., Department of Neurology, Lagos University Teaching Hospital, Lagos, Nigeria; Mvuala, R., Department of Internal Medicine, Clinic Ngaliema, Kinshasa, DRC, Congo; Oke, D.A., Department of Cardiology, Lagos University Teaching Hospital, Lagos, Nigeria; Manga, A., Orthopaedic Department, Hopital du Caisse Nationale de Prévoyance Sociale, Yaoundé, Cameroon; Rajaonera, T., Department of Anaesthesiology and Reanimation, Mother and Child Hospital, Antananarivo, Madagascar; Nwadinigwe, C., National Orthopaedic Hospital, Enugu, Nigeria; Pay Pay, E., Orthopaedic Department, Clinic Ngaliema, Kinshasa, DRC, Congo; Rabearivony, N., Department of Cardiology, Mother and Child Hospital, Antananarivo, Madagascar
Introduction: This study aimed to identify patients at risk for venous thromboembolism (VTE) among all patients hospitalised, and to determine the proportion of at-risk hospital patients who received effective types of VTE prophylaxis in sub-Saharan Africa (SSA). Methods: A multinational, observational, cross-sectional survey was carried out on 1 583 at-risk patients throughout five SSA countries. Results: The prevalence of VTE risk was 50.4% overall, 62.3% in medical and 43.8% in surgical patients. The proportion of at-risk patients receiving prophylaxis was 51.5% overall, 36.2% in medical and 64% in surgical patients. Low-molecular weight heparin was the most frequently used prophylactic method in 40.2% overall, 23.1% in medical and 49.9% in surgical patients. Discussion: This study showed a high prevalence of VTE risk among hospitalised patients and that less than half of all at-risk patients received an American College of Clinical Pharmacy-recommended method of prophylaxis. Conclusion: Recommended VTE prophylaxis is underused in SSA.